3-Ethylimidazo[1,5-a]pyridine-1-carbaldehyde, 98%, 250mg

N2,N6-Bis(((9H-fluoren-9-yl)methoxy)carbonyl)-D-lysine, 97%, 10g

3-[1-(tert-Butoxycarbonyl)piperidin-4-ylaminosulfonyl]benzoic acid, 95.0%, 1g

3-acetyl-6-chloro-4-(4-methoxyphenyl)quinolin-2(1H)-one, 95.0%, 500mg

2-(3-((4-Bromo-2-fluorophenoxy)methyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 1g

2,2-Difluoro-2-phenylacetamide, 90.0%, 1g

Di(pyridin-4-yl)methanone, 95.0%, 100mg

3-Fluoro-5-methoxybenzaldehyde, 95.0%, 500g

ETHYL 4-BROMO-3-(BROMOMETHYL)-1-METHYL-1H-PYRAZOLE-5-CARBOXYLATE, 95.0%, 1g

C-(1-Methyl-pyrrolidin-3-yl)-methylamine, 95.0%, 500mg

FAM test liquid C, lower phase containing methanol, 500 ml, glass packaging

Anti-Endo-M Polyclonal Antibody Biotin Conjugate1vial

6-BROMO-2,7-DICHLORO-QUINAZOLINE, 97.0%, 100mg